biote Corp. (NASDAQ:BTMD) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET
Company Participants
Simon Serowiecki - Investor Relations
Terry Weber - Chief Executive Officer
Bob Peterson - Chief Financial Officer
Marc Beer - Executive Chairman
Ross McQuivey - Chief Medical Officer
Conference Call Participants
Les Sulewski - Truist Securities
Jonna Kim - TD Cowen
Kaumil Gajrawala - Jefferies
George Kelly - ROTH MKM
Operator
Good day, and welcome to the Biote First Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Simon Serowiecki, IR representative from Advisory Partners. Please go ahead.
Simon Serowiecki
Thank you for joining us today. This afternoon, Biote published financial results for the quarter ended March 31, 2024. This news release is available on the Investor Relations section of the company's website. Terry Weber, Chief Executive Officer; and Bob Peterson, Chief Financial Officer, will host today's call.
Before we get started, I'd like to remind everyone that management will make statements during this call that include forward-looking statements regarding, among other things, the company's financial results, future performance and growth opportunities, business outlook, strategies, goals, research and development, manufacturing and commercialization activities, regulatory process operations, the impact of macroeconomic conditions to business, results of operations, financial conditions, and other matters.
These statements are not guarantees of future performance. They're subject to a variety of risks and uncertainties, some of which are beyond the company's control. Actual results could differ materially from expectations reflected in any forward-looking statement. These statements are subject to risks, uncertainties, and assumptions that are based on management's current expectations as of today.
Biote undertakes no obligation to update them in the future. Therefore, these statements should not be relied upon as representative of the company's views as of any subsequent date. For discussion of risks and other important factors that could affect our actual results, please refer to our SEC filings available on the SEC's website and in the Investor Relations section of our website, as well as risks and other important factors discussed in the earnings release.
Management will also refer to adjusted EBITDA, which is a non-GAAP financial measure, to provide additional information to investors. Reconciliation of the non-GAAP to GAAP measure is provided in earnings release, with the primary differences being stock-based compensation, fair value adjustment of certain liabilities, transaction-related expenses, and other non-operating expenses. Please refer to our first quarter 2024 earnings release for reconciliation of adjusted EBITDA to net income, the closest comparable GAAP measure.